Cell competition between wild-type and JAK2V617F mutant cells prevents disease relapse after stem cell transplantation in a murine model of myeloproliferative neoplasm is a research paper published in Experimental Hematology and Oncology (2021). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: R01 HL134970
U.S. Department of Veterans Affairs
Grant: BX003947
NCI NIH HHS
Grant: P01 CA247886
BLRD VA
Grant: I01 BX003947
NCI NIH HHS
Grant: R01 CA197296
National Institutes of Health
Grant: 5R01HL134970-03
Molecular and Cellular Biology of Megakaryocytes in Normal and Neoplastic Hematopoiesis
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Cell competition between wild-type and JAK2V617F mutant cells prevents disease relapse after stem cell transplantation in a murine model of myeloproliferative neoplasm
Additional file 1 of Cell competition between wild-type and JAK2V617F mutant cells prevents disease relapse after stem cell transplantation in a murine model of myeloproliferative neoplasm